Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates
Neuronetics (STIM) delivered earnings and revenue surprises of -18.18% and -2.21%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?